⌘K

Home/Filings/4/0001493152-23-018619

4//SEC Filing

DAVIS TRENT D 4

Accession 0001493152-23-018619

CIK 0001417926other

View on SEC.gov Company Profile

Filed

May 21, 8:00 PM ET

Accepted

May 22, 7:58 PM ET

Size

5.4 KB

Accession

0001493152-23-018619

Insider Transaction Report

Form 4

Period: 2023-05-18

INVO Bioscience, Inc.INVO

Director

Transactions

Award
Stock Option (right to buy)
2023-05-18+85,000→ 85,000 total
Exercise: $0.37Exp: 2033-05-17→ Common Stock (85,000 underlying)

Footnotes (1)

[F1]The option vests in four equal installments beginning on May 17, 2023 and on each calendar quarter-end thereafter until fully vested.

Documents

1 file

4
ownership.xmlPrimary

Issuer

INVO Bioscience, Inc.

CIK 0001417926

Entity typeother

Related Parties

1

filerCIK 0001217815

Filing Metadata

Form type: 4
Filed: May 21, 8:00 PM ET
Accepted: May 22, 7:58 PM ET
Size: 5.4 KB

View on SEC.gov